SLN
Silence Therapeutics PLC
10.90$
+1.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59,226.7% | – | 1,131.3% | 49,643.8% | – | – | 68.7% | 60.1% | 62.2% | 40.7% | 27.3% | 38.5% | |
| -59,126.7% | – | -1,031.3% | -49,543.8% | – | 100.0% | 31.3% | 39.9% | 37.8% | 59.3% | 72.7% | 61.5% | |
| 59,226.7% | – | 1,131.3% | 49,643.8% | – | 5,465.6% | 368.8% | 247.8% | 201.1% | 173.5% | 156.9% | 12,120.4% | |
| 21,720.0% | – | 514.9% | 40,400.0% | – | 3,951.6% | 255.2% | 161.2% | 118.6% | 81.3% | 62.1% | 3,997.1% | |
| 21,720.0% | – | 514.9% | 40,400.0% | – | 9,417.2% | 685.6% | 409.0% | 319.7% | 254.8% | 219.1% | 16,117.5% | |
| -80,846.7% | – | -1,546.2% | -89,943.8% | – | -9,317.2% | -654.3% | -369.0% | -281.9% | -195.5% | -146.4% | -16,056.0% | |
| 980.0% | – | 200.5% | 93.8% | – | 13.5% | 0.3% | 0.1% | 0.3% | 0.1% | – | – | |
| -79,866.7% | – | -1,345.7% | -23,593.8% | – | -9,373.0% | -657.8% | -369.4% | -229.3% | -198.3% | -102.8% | -15,849.9% | |
| -5,946.7% | – | -249.6% | -13,481.3% | – | -1,347.5% | -63.8% | -51.9% | 3.2% | -27.8% | 2.0% | 2.0% | |
| -73,920.0% | – | -1,096.1% | -10,112.5% | – | -8,025.4% | -594.0% | -317.4% | -232.4% | -170.5% | -104.7% | -15,851.9% | |
| -78,633.3% | – | -1,506.0% | -20,793.8% | – | -9,161.9% | -648.5% | -365.9% | -226.2% | -196.2% | -113.2% | -15,750.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.